Mease, Philip J. http://orcid.org/0000-0002-6620-0457
Accortt, Neil A. http://orcid.org/0000-0003-0522-0769
Rebello, Sabrina http://orcid.org/0000-0002-0201-4030
Etzel, Carol J. http://orcid.org/0000-0003-1516-6241
Harrison, Ryan W. http://orcid.org/0000-0003-4575-006X
Aras, Girish A. http://orcid.org/0000-0002-3180-4533
Gharaibeh, Mahdi M. F. http://orcid.org/0000-0003-2417-2862
Greenberg, Jeffrey D. http://orcid.org/0000-0001-9711-0457
Collier, David H. http://orcid.org/0000-0002-1220-3812
Clinical trials referenced in this document:
Documents that mention this clinical trial
Discontinuation and switching patterns of tumour necrosis factor inhibitors (TNFis) in TNFi-naive and TNFi-experienced patients with psoriatic arthritis: an observational study from the US-based Corrona registry
https://doi.org/10.1136/rmdopen-2018-000880
Persistence of tumor necrosis factor inhibitor or conventional synthetic disease-modifying antirheumatic drug monotherapy or combination therapy in psoriatic arthritis in a real-world setting
https://doi.org/10.1007/s00296-019-04345-1
Funding for this research was provided by:
Amgen
Article History
Received: 15 February 2019
Accepted: 11 June 2019
First Online: 18 July 2019
Compliance with ethical standards
:
: PJM has received research grants from AbbVie, Amgen Inc., Bristol-Myers Squibb, Celgene, Janssen, Eli Lilly, Novartis, Pfizer, Sun Pharmaceutical Industries Ltd., and UCB; has been a consultant for AbbVie, Amgen Inc., Bristol-Myers Squibb, Celgene, Galapagos, Janssen, Eli Lilly, Merck, Novartis, Pfizer, Sun Pharmaceutical Industries Ltd., UCB, and Zynerba; and has been a speaker for AbbVie, Amgen Inc., Bristol-Myers Squibb, Celgene, Genentech, Janssen, Novartis, Pfizer, and UCB. NAA and DHC are employees and stockholders of Amgen Inc. SR, CJE, RWH, and JDG are employees of Corrona, LLC. CJE is a stockholder of Corrona, LLC, and a member of an advisory board for Merck. JDG is a stockholder of Corrona, LLC, and has been a consultant to Genentech, Janssen, Pfizer, Eli Lilly, and Novartis. GAA and MMFG were stockholders of Amgen Inc. and employees of Amgen Inc. when the work was conducted. Corrona has been supported through contracted subscriptions in the last 2 years by AbbVie, Amgen Inc., Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Crescendo, Eli Lilly and Company, Genentech, Gilead, GlaxoSmithKline, Janssen, Merck, Momenta Pharmaceuticals, Novartis, Ortho Dermatologics (Bausch Health), Pfizer Inc., Regeneron, Roche, Sun, and UCB.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments.
: The Corrona dataset is based on a large US multicenter study adhering to a number of institutional review boards, with complex logistics. Patients did not provide consent to raw data sharing during the data collection for this purpose, and the Corrona data sharing policies do not permit raw data sharing for this purpose. An aggregated limited dataset from the current analyses is available to qualified investigators with an approved protocol. Data requests may be sent to Corrona, represented by Dr. Jeffrey D. Greenberg MD MPH, NYU School of Medicine, New York, NY, e-mail jgreenberg@corrona.org.